A leader in advanced image analysis, workflow solutions and radiotherapy, iCAD, Inc., will be at the upcoming 100th Annual Meeting of the Radiological Society of North America (RSNA) in Chicago this Sunday, November 30 to Friday, December 5 to present advanced computer-aided detection (CAD) solutions for early and accurate diagnoses of breast and colon cancer.
The company is scheduled to discuss the various features, capabilities and uses of their workflow and iCAD solutions through symposiums, posters, and interactive workshops. Attendees can visit booth no. 4135 in Hall A to learn more about what the company has to offer.
iCAD is scheduled to demonstrate their first proprietary technologies to receive FDA clearance for CTC: the PowerLook Advanced Mammography Platform (AMP)®, and VeraLook® CTC. The former was launched in 2012, and has since then expanded its capabilities to include a number of modules for assessing breast density, dose, and advanced analytics. Additionally, iCAD will be featuring a groundbreaking tomosynthesis workflow solution still in the pipeline.
“We are pleased to showcase our latest Cancer Detection technologies at the 100th RSNA meeting. Cancer Detection technologies have been proven to help radiologists identify cancer earlier, when there may be more treatment options available,” Ken Ferry, the President and CEO of iCAD said in a press release. “With medical imaging’s rapid evolution, iCAD continues to build its CAD offerings to ensure that radiologists have access to the most innovative solutions for optimal patient care.”
[adrotate group=”1″]
Aside from technology demonstrations, iCAD will be presenting the Xoft® cervical brachytherapy for gynecological cancer, MRI imaging for the characterization of pediatric brain tumors and a cloud-based, peer-review platform and workflow tool for extensive oncology networks. For a complete schedule of iCAD’s presentations, demonstrations and workshops, visit http://www.icadmed.com/rsna.html.
The company will also launch a campaign on social media for the benefit of the Imerman Angels, a local organization committed to providing one-on-one support to cancer patients, survivors, and caregivers. All of the conference’s attendees can get involved by posting what motivates them to “never stop looking”, and use the hashtag #MySight. For every Tweet or Facebook post that includes #MySight, iCAD will make a donation, and all posts on social media (Tweets, retweets, mentions, replies, Facebook posts) that use the official hashtag, posted between November 30 until December 4 are qualified for donation.
